{"transactions":[{"id":1700176,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:05:30.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on April 10, 2024, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. through the vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-23-129247","document":"tm2333705-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129247/tm2333705-4_4seq1.xml","form_type":"4"}},{"id":1911398,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-28T22:03:08.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6050},"source":{"system":"sec-edgar","filing":"0001104659-23-053227","document":"tm2313909-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053227/tm2313909-4_4seq1.xml","form_type":"4"}},{"id":1911397,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-28T22:03:08.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6050,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 7, 2022, the reporting person was granted 6,050 restricted stock units, vesting on April 7, 2023, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on April 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":8314,"source":{"system":"sec-edgar","filing":"0001104659-23-053227","document":"tm2313909-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923053227/tm2313909-4_4seq1.xml","form_type":"4"}},{"id":1921049,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-12T22:00:48.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the \"Company\") through the vesting date."}],"balance_after":39000,"derivative":{"exercise_price":0.99,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001104659-23-044711","document":"tm2312600-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923044711/tm2312600-2_4seq1.xml","form_type":"4"}},{"id":2046516,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-25T21:16:40.000Z","date":"2023-01-20","kind":"exercise","acquired":false,"shares":2264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2264},"source":{"system":"sec-edgar","filing":"0001104659-23-006545","document":"tm234334-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006545/tm234334-2_4seq1.xml","form_type":"4"}},{"id":2046515,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T21:16:40.000Z","date":"2023-01-20","kind":"exercise","acquired":true,"shares":2264,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 22, 2021, the reporting person was granted 2,264 restricted stock units, vesting on December 22, 2022, subject to the reporting person's employment on that date. Such restricted stock units were converted into common stock on a one-for-one basis (after adjusting for the Reverse Stock Split) on January 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On November 30, 2022, Petros Pharmaceuticals, Inc. effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"), effective as of 4:05 p.m., New York time. All share amounts reported herein have been adjusted to give effect to the Reverse Stock Split."}],"balance_after":2264,"source":{"system":"sec-edgar","filing":"0001104659-23-006545","document":"tm234334-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923006545/tm234334-2_4seq1.xml","form_type":"4"}},{"id":2299484,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-11T21:00:56.000Z","date":"2022-04-07","kind":"grant","acquired":true,"shares":60505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date."}],"balance_after":60505,"derivative":{"underlying":"Common Stock","underlying_shares":60505},"source":{"system":"sec-edgar","filing":"0001104659-22-044713","document":"tm2212468d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922044713/tm2212468d2_4.xml","form_type":"4"}},{"id":2440237,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-07T21:44:27.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":22642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one year anniversary of the date of grant, subject to the reporting person's employment on that date"}],"balance_after":22642,"derivative":{"underlying":"Common Stock","underlying_shares":22642},"source":{"system":"sec-edgar","filing":"0001104659-22-002304","document":"tm222320d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465922002304/tm222320d2_4.xml","form_type":"4"}},{"id":2752196,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":95832,"kind":"person","name":"Bradley Greg","position":1,"cik":"0001833504","reported_name":"Bradley Greg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-04-09T20:16:50.000Z","date":"2021-04-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 25% on the date of grant, 25% shall vest upon the six-month anniversary of the date of grant and the remainder shall vest in equal installments over the following four fiscal quarters."}],"balance_after":50000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-007864","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921007864/doc1.xml","form_type":"4"}}]}